SanMelix Laboratories

Helping You Heal with Honey

SanMelix Laboratories

Helping You Heal with Honey

HOLLYWOOD, FL
Consumer Products
Pharmaceutical
Our Goal is Simple, Faster and Healthier Healing

$490,825

raised
810
Investors
41
Days Left
$0.60
Price per Share
$6.56M
Valuation
Equity
Offering Type
$249.60
Min. Investment

$490,825

raised
810
Investors
41
Days Left
$0.60
Price per Share
$6.56M
Valuation
Equity
Offering Type
$249.60
Min. Investment

Bonus Rewards

Get rewarded for investing more into SanMelix Laboratories

$249+
Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.
$500+
Investment
5% Bonus Shares
If you invest $500+, you will receive 5% bonus shares
$1,000+
Investment
10% Bonus Shares
If you invest $1,000+, you will receive 10% bonus shares
$2,500+
Investment
15% Bonus Shares
If you invest $2,500+, you will receive 15% bonus shares
$5,000+
Investment
20% Bonus Shares
If you invest $5,000+, you will receive 20% bonus shares

Reasons to Invest

First MGO honey-based wound dressing patented formulations with anticipated FDA microbial claim
Our advanced wound care dressings will address the antimicrobial resistance (AMR) crisis
Our bioactive buckwheat honey products promote faster and healthier healing



Bringing faster healthier healing to all



Invest in SanMelix

Using the natural healing properties of Buckwheat honey, combined with our advanced bioactive enhancements, SanMelix has created a product that aids in the healing of acute, chronic and minor wounds. With IP protection on our BEECure™ M dressing and other pending patents, co-created by a renowned Harvard trained podiatric physician, SanMelix's advanced bioactive wound care products can be used in a host of settings and situations. We have created over-the-counter (OTC) skin care products such as ointments and creams designed to help in the healing of minor burns, scrapes, radiodermatitis and more. Our products will also be used for advanced wound care in hospitals and rehabilitation centers, by physicians through the use of dressings and ointments.


We have a talented and world-renowned physician group who puts patient care first. Our goal is to improve the lives of patients and help speed up the healing process using the natural therapeutic properties that already exist in buckwheat honey. Honey has been used in medicine since 8000 BC because of its unique healing properties and with our team of doctors and scientists, we have enhanced it through the use of broad-spectrum antimicrobials. Dr. Sabacinski developed the BEECure™ dressings to help prevent the dangerous side effects and adverse drug interactions that often arise with the use of predominantly synthetic pharmaceuticals. 


Dr. Sabacinski has been working in the wound care space for over thirty years, and he knows the patients’ needs for a product that encourages fast wound closure and provides protection from bacteria and infection. Our mission at SanMelix is to help people. We want to give caregivers, physicians, and the general public the ability to heal wounds using a natural product that’s been used for centuries. At SanMelix, the proof is in our buckwheat honey.


With the funds raised through StartEngine, we plan to complete the testing on our products as well as prepare inventory. Our first product launch will be our OTC cosmetic line. We have an agreement with a European company to license or purchase the CE Marked formulation for our first buckwheat honey skin care product and will use the funds to help complete this arrangement.

The entire population requires wound care




But synthetic wound care products have issues


  • Potentially dangerous side effects can occur from entirely synthetic wound care products
  • There are environmental consequences to the manufacturing of chemical based products
  • There are multi drug resistant super infections such as MRSA and A. baumannii
  • Skin grafts and skin substitutes require repeated application
  • There are few effective therapies for radiotherapy, laser therapy and minor thermal burns
  • Often severe wounds can result in amputations

Using natural products we can solve them


  • Our BEECure™ M (buckwheat honey MGO) patented formulation reduces microbial growth and provides a barrier to prevent life threatening bacteria (MRSA)  from penetrating the dressing
  • Case studies using BEECure ™ M illustrated accelerated healing and skin regeneration on severe limb threatening wounds
  • Need for fewer applications of skin grafts and skin substitute when honey dressings are applied to graft
  • Buckwheat honey reduces scarring and inflammation related to radiotherapy, laser therapy and minor thermal burns
  • SanMelix OTC buckwheat honey formulations would be considered a first aid antibiotic/antiseptic/antimicrobial to treat minor cuts, scrapes and burns
  • Greener product in use and in manufacturing

We create products using Buckwheat Honey

We are focusing on the unique medicinal properties of Buckwheat Honey for tissue regeneration and accelerated healing. Our bioactive buckwheat honey formulations demonstrate intrinsic healing activity with anti-microbial additives to prevent infection. SanMelix has a patent on its BEECure™ M formulation and Dr. Sabacinski has co-invented 2 additional patent pending natural Buckwheat Honey BEECure™ medical devices which also demonstrated superior clinical outcomes. Studies have proven that buckwheat honey has superior medicinal properties to Manuka honey and other natural remedies. Our products also have higher standardization and broader spectrum anti-microbial activity achieving consistent clinical outcomes. Buckwheat honey also has higher anti-inflammatory and anti-oxidant activities than other products currently being used. 


The anti-oxidant properties in Buckwheat honey assist in wound closure and help to stimulate the wound healing process. This means wounds are healing faster and better without the risk of further complications that could be a great hindrance to the lives of patients. Our Buckwheat honey patented formulation creates a microbial barrier to prevent life-threatening bacteria from penetrating through the dressing while it is in use. The nutrients in the honey help spur tissue regeneration because it contains large quantities of easily assailable sugars, amino acids, vitamins, specifically vitamin C. Our products are made to heal chronic and difficult to close wounds.

Our Products in Use

Our BEECure™ products can be used for a wide variety of skin irritations and advanced wound care. Because of the antimicrobial claim in our wound care dressings, they will be instrumental in the treatment and healing of:

  • Ulcers, diabetic and otherwise
  • Skin grafts
  • Burns
  • Trauma and triage
  • And more!

Previously we were working in tandem with Trauma insight, who formed a CRADA with the Airforce to perform the 510(k) performance and microbial barrier testing. Due to the Coronavirus Disease 2019 (“COVID-19”) our biocompatibility testing with the Air Force was postponed after the Air Force had completed some of the initial in vitro 510(k) testing. We are establishing relationships with additional GLP testing facilities to conduct the remaining 510(k) testing. Once we receive our FDA pre-market clearance, we anticipate working with Trauma Insight as our CRO for clinical trials.


The advanced wound care BEECure™ M dressing is currently in the testing phase. The radiodermatitis cream is in the testing phase and anticipated to launch in Q4, 2020. All other products have not yet been developed.

Advanced Wound Care (AWC)

BEECure™ M wound dressings

BEECure™ I wound dressings

BEECure™ B wound dressings

*BEECure I and BEECure B wound dressings are currently in development. BeeCure M wound dressing are in testing phases

Over The Counter (OTC)

BEECure™ R (radiodermatitis)

BEECure ™ Skin Care

BEECure™ Minor Burns

BEECure™ DFU Cream

*BEECure™ R is currently in development. 

The difference is in the ingredients

Although manuka honey is the most commonly used honey-based wound treatment on the market, studies have shown that buckwheat honey has superior inherent healing properties when compared to manuka honey due to its higher anti-inflammatory and higher anti-oxidant activities.  In addition, SanMelix’s advanced wound care products have been fortified with antimicrobials to ensure a higher standardized and broader spectrum antibacterial activity. Our patented formulation utilized in our AWC dressings permits SanMelix to launch one of the first bioactive honey dressing to make an antimicrobial claim in the U.S. Our honey dressing is currently in development.. Our bioactive dressing will be for any wound type of any depth and severity. The dressing will prevent biofilms from forming,  control wound odor, reduce pain and treatment time while being cost-effective and more environmentally sound. 


Additionally, there will be improved skin and tissue regeneration and debriding action. This prevents the necessity for excess skin grafts or skins substitutes, which run the added risk of infection or rejection. Studies have shown buckwheat honey has bactericidal activity against antibiotic-resistant pathogens.


The bottom line is that our enhanced Buckwheat honey dressings and ointments are making the lives of patients and doctors easier. We are here to assist in the healing process and make a painful experience as painless as possible. We have seen firsthand the need for such products as the ones we've been creating and know that our BEECure™ products are going to be a big step forward in changing the lives of many. 



Natural ingredients that reduce inflammation and rehydrate your skin

Securing powerful partnerships

 Through our previous collaboration with our Contract Research Organization, Trauma Insight, we were able to establish a collaboration with the Air Force in order to conduct preclinical research that supported the 510(k) product testing. Some of our in-vitro testing was completed in November 2019; however, due to the Coronavirus Disease 2019 (“COVID-19”), the remaining 510(k) testing was postponed by the Air Force. We are establishing relationships with additional GLP testing facilities to complete our 510(k) pre-market clearance testing. 


We are looking to continue testing our advanced wound care products to obtain 510(k) pre-market clearance from the FDA and to continue prosecuting our other two patent pending formulation applications. We have an agreement with a European company to distribute its existing buckwheat honey CE Mark products for radio-dermatitis and laser therapy induced skin reactions and secure our main authentic raw buckwheat honey supplier.


On top of this, we are negotiating with other GMPs to contract manufacture our skin care products. We will continue to test, research and expand our products utilizing world renown physicians and scientists.


We are thrilled about all that lies ahead for the SanMelix team and the effect our nature-based products will have on healing.

A team of experts

SanMelix is proud to have some of the most experienced and widely renowned minds behind our products. Dr. Kenneth Sabacinski has worked in the advanced wound care space for over thirty years. He is a podiatric physician who started his training at Harvard Medical School and Beth Israel Deaconess Medical Center in Boston. People come from all over the world to see him for treatment of limb and life-threatening wounds including diabetic-related foot ulcers.


In addition to co-founder Dr. Sabacinski, our medical team of experts includes Dr. Jason Green, D.O. Board Certified Dermatologist, and COL (ret) George E. Peoples, MD, FACS. Dr. Green is our Advisory Board Director and is currently performing product testing of our initial CE Mark skin care product for radiodermatitis. Dr. George Peoples is the founder of Trauma Insight. Through his military career as a staff surgeon at a level I trauma center and multiple combat deployments, Dr. Peoples has extensive trauma experience and has developed close relationships with some of the most prominent military and civilian trauma and critical care physicians in the country.


Diana Sabacinksi and John Kaufman also serve as directors. Diana has over 25 years of accounting experience across a swath of fields, as well as starting her career in a Big 4 CPA international accounting firm.  John Kaufman is the founder of InteSec Group Fla LLC. He also founded Be Power Tech Inc. and served as its Chairman, Director, co-patent holder, and consultant. Together, the directors boast business acumen and scientific prowess and along with partnerships with other leading researchers and scientists, SanMelix is proud to have such strong and exciting leaders at the helm.

Dr. Kenneth Sabacinski

Diana Sabacinksi

Bringing buckwheat honey's healing power to skin care

Our skin care product line will provide honey based ointment for a myriad conditions like radiodermatitis, rashes, acne and much more. We have completed skin irritation tests on our radiodermatitis cream and anticipate launching in Q4,2020. Our initial skin care product will be regulated under the United States Federal Food, Drug, and Cosmetic Act. The FDA OTC monograph program will use the patent pending formulations while using already recognized FDA products to enhance our creams and ointments. 

BEECure™ products can be used for or as a(an):

  • Acne Treatment
  • Antiseptic Bandage
  • Diabetic foot cream
  • Burn Care Ointment
  • Radiodermatitis
  • Eczema
  • Eye drops
  • Eczemema
  • Diaper Rash
  • And more!

What people are saying

Help us improve lives

There are over 50 million reported cases globally of patients suffering from hard-to-close wounds. 15% of these are diabetic foot ulcers that eventually lead to amputation. SanMelix BEECure™ bioactive wound care products are here to treat everything from a minor scrape to a severe wound and everything in between. Using our unique enhanced Buckwheat honey formulations fortified with microbial barriers, we are treating all types of dermal afflictions by speeding up the healing process and reducing pain and the risk of infection. 


Honey is a product that's been used all throughout history as a healing and restorative agent, and we are harnessing its natural powers and using our years of scientific and medicinal studies to enhance it. We are regulating it to make it safe for hospital use, as well selling it OTC to the average consumer. Everyone should be able to experience the benefits of the BEECure™ Buckwheat honey products. 


Our customers will include the VA & DoD, medical supply distributors, physician networks, hospitals, SNFs as well as indirect sales channel for private label/ white label for OTC opportunities. We will market directly to OTC consumers through digital marketing and social media. We are capitalizing on a market that has been desperately in need of a natural and safe product that promotes healing and tissue growth among many other benefits. 


We have a talented and world-renowned physician group who puts patient care first. Our goal is to improve patients' lives in need of healing with our innovative bioactive wound care and skin care products.

Offering Summary


Company

:

SanMelix Laboratories, Inc.

Corporate Address

:

1150 North 35th Avenue Suite 225, HOLLYWOOD, FL 33021

Offering Minimum

:

$9,999.60

Offering Maximum

:

$1,069,998.00

Minimum Investment Amount

(per investor)

:

$249.60











Terms


Offering Type

:

Equity

Security Name

:

Common Stock NV

Minimum Number of Shares Offered

:

16,666

Maximum Number of Shares Offered

:

1,783,330

Price per Share

:

$0.60

Pre-Money Valuation

:

$6,561,600.00











*Maximum subject to adjustment for bonus shares. See Bonus info below

Investment Bonuses

If you invest $500+, you will receive 5% bonus shares.

If you invest $1,000+, you will receive 10% bonus shares.

If you invest $2,500+, you will receive 15% bonus shares.

If you invest $5,000+, you will receive 20% bonus shares.

The 10% Bonus for StartEngine Shareholders

SanMelix Laboratories, Inc. will offer 10% additional bonus shares for all investments that are committed by StartEngine Crowdfunding Inc. shareholders who invested over $1,000 in StartEngine's own offerings.

StartEngine shareholders who invested $1,000 or more in any StartEngine offering will receive a 10% bonus on this offering. This means you will receive a bonus for any shares you purchase. For example, if you buy 100 shares of Common Stock NV at $0.60 / share, you will receive 110 Common Stock NV shares, meaning you'll own 110 shares for $60. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% bonus is only valid for one year from the time StartEngine Crowdfunding Inc. investors received their countersigned StartEngine Crowdfunding Inc. subscription agreement.

Irregular Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments.

Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$252,210.00 USD
$259,432.00 USD
Cash And Cash Equivalents
$51,318.00 USD
$78,623.00 USD
Accounts Receivable
$0.00 USD
$0.00 USD
Short Term Debt
$18,738.00 USD
$4,272.00 USD
Long Term Debt
$0.00 USD
$0.00 USD
Revenues And Sales
$0.00 USD
$0.00 USD
Costs Of Goods Sold
$0.00 USD
$0.00 USD
Taxes Paid
$0.00 USD
$0.00 USD
Net Income
-$183,696.00 USD
-$290,978.00 USD

Risks

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.


Updates

Happy 4th!

5 days ago

Hi everyone, 

We are thrilled to announce we received our 2nd patent this week. Thanks very much to the 700+ investors who have joined our investor team already, we really wouldn't be here without the support of our investors, so we sincerely appreciate it. Again, we have exciting products in the works, so please stay tuned. We wish you and your loved ones a happy and safe 4th! 

A close up of text on a white background

Description automatically generated

The SanMelix Team

 

Heading to 500K

6 days ago

Hi everyone,

 

We are very excited our campaign is still building momentum. Because of you, we had over $64K in commitments for June.  We thank you for believing in what we are trying to achieve, and stepping in to join us on this journey. Some of our new investors may have received a notice to reconfirm their investments as we had material changes. If you have not already logged back into your account to ensure you are still participating in our journey, please do it today. Again, thank you for your continued support and commitment.

 Stay safe, 

 Diana

Notice of Funds Disbursement

13 days ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, SanMelix Laboratories has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in SanMelix Laboratories be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

Moving Forth

19 days ago

Hello all, 

This week we entered into an agreement with Product Launchers a company that fuses timeless and proven product launching principles with modern, effective sales and marketing techniques to help us grow both in-store and online. Product Launchers will launch our radiodermatitis cream on Amazon in Q4. Please share this exciting news with your friends and family, and if you are new to our family, remember to log back into your account to reconfirm your investment. 

Bee Well, 

Diana


Exciting News!

20 days ago

Hello, 

Today we have surpassed another milestone with over $450k invested in our campaign. We sincerely thank you all for your support. Please encourage family and friends to invest as well.  Our campaign is updated to reflect the launching of our radiodermatitis product in Q4. lookout for an email from StartEngine that will require reconfirmation of your investment. 

 Bee well, 

 The SanMelix Team. 

Notice of Material Change in Offering

21 days ago

[The following is an automated notice from the StartEngine team].

Hello! Recently, a change was made to the SanMelix Laboratories offering. Here's an excerpt describing the specifics of the change:


SanMelix updated their campaign page and extended their campaign.


When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.

Staying connected through difficult times

27 days ago

Hi everyone, 

We hope you are all staying safe and well. While it is too early to declare a recovery, it’s ok to smile again. At SanMelix we are jazzed up and welcome our new 114 investors in the month of May to our family. We sincerely thank you for your trust and commitment. As we mentioned previously, we are working diligently to launch our Radiodermatitis BEECure™-R   product in Q4.  This product is specially formulated to moisturize and help dry skin resulting from radiation therapy or laser treatment, and heat and sun exposure. We will keep you posted on our progress, so look out for updates. We will all march again if we stand together.

Best,

Diana

Still building momentum

about 1 month ago

Just a quick note from SanMelix.  Even with these unprecedented times our campaign has surpassed the significant $400k milestone with 89 investors joining us this month alone!  We sincerely thank our shareholders as we look forward to our path ahead. If you haven’t yet, don’t miss the opportunity to own a piece of the company that is creating a product that aids in the healing of acute, chronic and minor wounds. To our recent investors, remember to log back into your email for notifications regarding reconfirming your investment.  Again, we appreciate the support and confidence.  Please share our campaign with your friends and family. 

Stay Safe, 

The SanMelix Team

Notice of Funds Disbursement

about 2 months ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, SanMelix Laboratories has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in SanMelix Laboratories be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

We are Surviving!

about 2 months ago

Dear Investors, 

We know there is a great sense of unease everywhere. We would also like to reassure you that as a company we are resilient. Not only are we surviving this economic downturn, but we have noticed an increase in investments. Today we have surpassed $400K thanks to you! We appreciate your continued support and confidence. We will get through this crisis and emerge happier and thankful for the things that matter most. 

At SanMelix our enhanced Buckwheat honey dressings and ointments will make the lives of patients and doctors easier. We are here to assist in the healing process and make a painful experience as painless as possible. Please, do look after yourselves and your families.

Diana

Another Milestone Achieved

2 months ago

Hi Everyone, 

We are happy to report that we have reached another milestone, and faster than anticipated. We have exceeded 375K and looking forward to raising more. We regard our investors as valuable contributors to our team and even more excited about our bright future. We are busy as bees here, and as a result of the response and momentum, we have decided to extend our campaign to allow more people to join us on this journey and reach our next goal of $500k. 

Now, the countdown begins, and we need your help to reach our next goal. Please share our link below with friends and family. https://www.startengine.com/sanmelix

Also remember to do your part and stay home and healthy!

Diana


Notice of Material Change in Offering

2 months ago

[The following is an automated notice from the StartEngine team].

Hello! Recently, a change was made to the SanMelix Laboratories offering. Here's an excerpt describing the specifics of the change:


San Melix provided updated financials and extended their campaign.


When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.

Notice of Funds Disbursement

3 months ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, SanMelix Laboratories has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in SanMelix Laboratories be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

Fellow Investors

3 months ago

Hi Everyone, 

Lately, we’re getting a lot of questions about coronavirus. The thing is, you never know when an event, like COVID-19, could come along and rattle the global economy. But that doesn’t mean we need to panic. Try to keep your eyes on the horizon. This will pass eventually. Continue to be confident you invested in the right company. Our patented formulation utilized in our bioactive dressing will be for any wound type of any depth and severity. In addition, Studies have shown buckwheat honey has bactericidal activity against antibiotic-resistant pathogens. Stay safe, healthy, and take a few minutes a couple of times a day to take slow, deep breaths - and smile.

Please share our link with friends and family. www.startengine.com/sanmelix

 

Diana

 

Your Investment!

3 months ago

Hi everyone,

I Hope you and your family are staying safe. We are all in a bad situation right now, but we need to stay focused and connected. As an investor myself and knowing our products will lead to happier and healthier lives I’m in for the long haul, and trust you are too. The total addressable bioactive wound care market by 2026 is in the BILLIONS, so be confident you invested in the right company.   To our recent investors, remember to log back into your email for notifications regarding reconfirming your investment.  Again, we appreciate the support and confidence. Together, we will get through this tough situation. 

 Be well, 

 Diana 

Stay Safe

4 months ago

Wellness is our highest priority!  We want to express our sincere concern for everyone who has been impacted by the coronavirus (COVID-19). You are undoubtedly experiencing significant disruptions to your life and routine. We will continue to follow the latest recommendations from the centers for disease control and prevention (CDC), and we’ll keep you updated on any changes within our organization.

 Stay Safe 

 The SanMelix Team 

Notice of Material Change in Offering

4 months ago

[The following is an automated notice from the StartEngine team].

Hello! Recently, a change was made to the SanMelix Laboratories offering. Here's an excerpt describing the specifics of the change:


Extended length of campaign.


When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.

BIG News!

4 months ago

This month SanMelix:

  1. Surpassed our $350k goal
  2. 510(k) testing came back with positive results
  3. USPTO issued Notice of Allowance for our 2nd Patent “wound healing composition and methods of use”

We are building an incredible team here at SanMelix that includes not only dedicated board members, but you, our beloved investors! We’re thrilled to have you as part of our team. With our momentum increasing and significant goals accomplished, we have decided to extend our campaign. Be on the lookout for an email to log back into your account and confirm you are still participating in our journey. 

Again, we thank you for your enduring support and embrace those followers who will decide to join us in the future. Please share our campaign with your friends and acquaintances and let them know how our patented technology can increase overall health and happiness. 

Best, 

Diana

350k and Rising!

4 months ago

Hi everyone,

We are excited and appreciative of our investors and the momentum gained since January (114k+ was raised in just over 2 months!). With your commitment, 2020 will be a transformational year, and we want to make sure everyone has an opportunity to invest! We are looking forward to  new partnerships, and growth! Be sure to watch for updates and share the link below with friends and family. www.startengine.com/sanmelix

Best,

The SanMelix team.

 

510(k) Testing Results!

4 months ago

Hi everyone, 

 I have exciting news to share with our incredible Investor Team, our shareholders, now at almost 500 strong. Our initial 510(k) testing came back with positive results. Our dressings showed antimicrobial properties, and the Minimum Inhibitory Concentration (MIC) report demonstrated buckwheat honey plus MGO was more effective than buckwheat honey alone for antimicrobial purposes. We have proved what we already know “Bringing faster healthier healing to all”. Your support and participation made these efforts a success.

 If you haven’t yet, don’t miss the opportunity to own a piece of this company. Please share with your family and network.

 

My warmest regards, 

Diana Sabacinski, 

CEO

 

 

Notice of Funds Disbursement

4 months ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, SanMelix Laboratories has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in SanMelix Laboratories be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

Press Release

4 months ago

Hi everyone,

We are delighted to share our latest press release where our CEO discusses our Bioactive Wound Care BEECure™, Approval Process, IP Protection and Growth Drivers with Stock News Now. Please share this with your fellow investors, friends and family. View the press release HERE.

Keep your eye out for more updates coming soon!

The SanMElix Team.

SanMelix Interview

4 months ago

Hi everyone,

We are very excited to share a recently published video from an Investor event in Texas.  At this event we met with small VCs and high net worth investors. Look at the video HERE.

 As always, stay tuned for our next update.

Diana

CEO Presented

4 months ago

Hi Everyone,

We were invited by the founder of Angels and Entrepreneurs to attend their retreat in Miami this past weekend.  SanMelix was one of seven organizations selected to present to 150+ investors, which led to multiple investments and commitments to our campaign. The Angels & Entrepreneurs Network is the first of its kind – showing ground-floor opportunities into some of the world’s hottest startups and trendiest enterprises, those determined to change the world… and show investors huge profits along the way. Again, if you haven’t yet, don’t miss the opportunity to own a piece of this company. Please share with your family and network.


 

All the best, 

Diana

A Huge Thank You!

5 months ago

Hi Everyone, 


We are over 300K and would like to extend our sincere thanks to those individuals that have invested in our vision. We think of you as part of our SanMelix family. We look forward to a future of building wealth for all of us and enhancing the lives of people through the use of our products. If you haven’t yet, don’t miss the opportunity to own a piece of this company. Please share with your family and network.

 

All the Best, 

 Diana 

What A Great Start!

5 months ago

Hi everyone,

Not only have we exceeded our goal of $250k in 2019, we are on the way to reach our next goal of $300k within the first 45days of 2020. We sincerely thank our shareholders as we look forward to the joint path ahead. If you haven’t yet, don’t miss the opportunity to own a piece of the company that is creating a product that aids in the healing of acute, chronic and minor wounds. Please share our journey with friends and family. 

Thank you again for your  continued confidence and support

 

Diana Sabacinski, CEO

 

Notice of Funds Disbursement

5 months ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, SanMelix Laboratories has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in SanMelix Laboratories be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

2019 SanMelix Highlights

5 months ago

Hi everyone, 

It was another busy year with more notable accomplishments as we made significant strides toward the future. We accomplished more milestones, including the following: 


  • Patent - USPTO Issued our first patent US 10,500,235 B2

 

  • Honey - We secured an authentic raw buckwheat honey supplier

 

  • Samples - Manufactured our bioactive BeeCure™ MGO (AWC) dressing samples 

 

  • Testing - The Air Force began testing our product for 510(k) clearance 

 

  • Team - Added a research scientist, reimbursement specialist and an advanced wound care expert to our team. 

 

  • Raise - We launched our equity crowdfunding campaign 

 

 We look forward to a successful 2020 as we build on the SanMelix brand and continue to develop, manufacture and market innovative, high-value skin care and advanced bioactive wound care products. On Behalf of SanMelix Laboratories, Inc. thank you for your continued confidence in us.

Best,

Diana

Check Your Email

5 months ago

Hi everyone,

If you invested in the past couple of months please be on the lookout for an email from StartEngine to reconfirm your investment.  Once you receive the email log back into your account and confirm you are still participating in our journey. We really appreciate your support and thank you again for your confidence and support.

Diana Sabacinski


380 Investors

6 months ago

Hi Eveyone, 

We can't be more pleased and thankful to all our 380 investors who have supported our journey.  The SanMelix campaign has rapidly raised over $275K since our launch and our speed is only accelerating! 

We look forward to updating you weekly with exciting news, updates, and happenings as we grow and expand our campaign! 

 

Thank you!

The SanMelix Team

Happy New Year

6 months ago

Hi everyone,

Thanks to you we are off to a great start in 2020. We surpassed our $250k goal today and have decided to extend the campaign. Be on the lookout for an email to log back into your account and confirm you are still participating in our journey. 

We’re thrilled to have you as part of our team. And if you haven’t yet, don’t miss the opportunity to own a piece of the company that is creating a product that aids in the healing of acute, chronic and minor wounds. Thank you again for your confidence and support.

Diana Sabacinski and the SanMelix team. 

 

Notice of Material Change in Offering

6 months ago

[The following is an automated notice from the StartEngine team].

Hello! Recently, a change was made to the SanMelix Laboratories offering. Here's an excerpt describing the specifics of the change:


Extended length of campaign.


When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.

Notice of Funds Disbursement

6 months ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, SanMelix Laboratories has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in SanMelix Laboratories be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

Just $25k More

7 months ago

Hi everyone, 

We are at $225k of our $250k GOAL. Help us reach this milestone by sharing our journey with your friends and family. Thank you so much to everyone who has followed us, we really appreciate your support!

Have a wonderful holiday!

Diana 

6 Days Left

7 months ago

Hi Everyone, 

Hope you are all enjoying the holiday season and the Holiday Bonus we are offering. There are only 6 DAYS LEFT TO INVEST with the bonus, so please share with your friends and family. 


Thank you for your continued support!

Notice of Funds Disbursement

7 months ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, SanMelix Laboratories has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in SanMelix Laboratories be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

Watch out for Notice

7 months ago

Hi everyone,

If you invested recently please be on the lookout for an email from StartEngine to reconfirm your investment.  Once you receive the email log back into your account and confirm you are still participating in our journey. We really appreciate your support and thank you again for your confidence and support.

Diana Sabacinski

CEO

Reaching our Goal!

7 months ago

Hi Everyone, 

The Holiday Season is here, and we are celebrating! We are getting closer to our $250k goal and All SanMelix investors are eligible for a holiday bonus before Christmas. Please continue to share with your family & friends and have them invest in a company that heals. If you have already invested, we sincerely thank you for your support and commitment. 

Happy Holidays

The SanMelix Team 

PATENT NUMBER

7 months ago

SanMelix Laboratories, Inc.  is proud to announce the grant of US Patent No. 10,500,235 B2. The patent covers Wound Healing Compositions Comprising Buckwheat Honey and Methylglyoxal and Methods of Use. The grant of that patent provides further recognition of the quality of the innovation being carried out by the SanMelix team. Please share with your network.

Thank you for your support,

Diana C.E.O.

Director Update

7 months ago


Hi everyone,

Since we added a new Director a Notice of Material Change in Offering was sent to everyone.   If you invested recently you should have received an email from StartEngine to reconfirm your investment. Be on the lookout for this email and log back into your account and confirm you are still participating in our journey. We really appreciate your support and thank you again for your confidence and support.

Diana Sabacinski

CEO

Another Team Member

7 months ago

Hi everyone,

The Sanmelix team is growing strong with the addition of Hamid Khosrowshahi as our newest Board Member focusing on Business Development. Hamid’s experience includes Owner of FloSure Technologies, LLC, Founding Partner/President of Propsera Technologies, LLC, and President of BioCore Medical Technologies. Hamid possess a wealth of knowledge in the medical device industry, including negative pressure wound care. Please help us heal others and continue to share our mission with your network and get them to invest in a company that cares!

All the best, 

Diana Sabacinski, CEO


Notice of Material Change in Offering

7 months ago

[The following is an automated notice from the StartEngine team].

Hello! Recently, a change was made to the SanMelix Laboratories offering. Here's an excerpt describing the specifics of the change:


SanMelix Laboratories, Inc. has updated their Board of Directors.


When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.

Surpassed Milestone

7 months ago

Hey SanMelix Family! 

I hope each and everyone of you enjoyed your thanksgiving weekend!  We wanted to let you know our campaign is doing great.  By the time this update reaches you, we have likely passed our milestone of $200K and getting closer to our $250k goal every day. We regard our investors as valuable contributors to our team, building the SanMelix brand with engagement by sharing our story with friends, family and business contacts. Please help SanMelix get over the next big hump! 

In gratitude,

Diana Sabacinski, CEO

Check Your Email

8 months ago

Hi Everyone, 

We decided to keep the momentum going so we extended our campaign. If you invested recently you should have received an email from StartEngine to reconfirm your investment. Please log back into your account and confirm you are still participating in our journey. We get very excited when we see how many people are investing even just a little bit because they believe in our products and our mission. We again express our appreciation for your confidence and support.

Best regards,

Diana 

CEO SanMelix

The Gift of Healing

8 months ago

Hi Everyone, 

Today we are celebrating that we've reached over 250 investors milestone on our StartEngine campaign! As we are nearing the holiday season, if you haven’t already, join us today and invest in the company that gives the gift of healing. If you have invested, thank you for your support and commitment. 





Notice of Material Change in Offering

8 months ago

[The following is an automated notice from the StartEngine team].

Hello! Recently, a change was made to the SanMelix Laboratories offering. Here's an excerpt describing the specifics of the change:


Extended length of campaign.


When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.

Expanding our Story

8 months ago

Hello everyone,

Recently Diana Sabacinski, our CEO, was interviewed by CEOCFO magazine. This magazine has been publishing since 2000, and is a brand recognized for their Top Executive interviews. See the article HERE and please share with your network. We've got a few more exciting updates in the lineup so stay tuned. Thank you everyone!



Notice of Funds Disbursement

8 months ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, SanMelix Laboratories has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in SanMelix Laboratories be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

New Team Member

8 months ago

Hello Everyone,

We are thrilled to announce Randall Carson has joined our team in the role of Director of Reimbursement. Randall’s experience includes Director of Government Affairs & Product Reimbursement at Smith & Nephew, North America, Manager of Product Reimbursement at Covidien and Organogenesis, Inc., and over 20 years’ working in the medical device and biologics industry.  We have reached 200 Investors!! Thank you all so much for your support. Please share our campaign with any friends and family.

Thank you,

The SanMelix Team 

Hand Selected to Present

9 months ago

Hi everyone, 

Due to a lot of interest in our company, we are excited to share we were hand selected to present our company at the MicroCap Rodeo in Texas last week. This gave us the opportunity to meet small VCs and high net worth investors. If you have friends that would be interested in SanMelix, please let them know that this is a unique opportunity to get involved!  Stay tuned for our next update.

Best Wishes, 

Diana Sabacinski, CEO

The Holy Grail

9 months ago

Hi Everyone,

This week we attended the Military Medical Industry Day in San Antonio, Texas. We met with researchers, developers, and representatives from all three services. During a one on one session they called our dressing “the holy grail” because it contains all three necessary mechanisms for healing. These include debridement, microbial barrier, and skin regeneration. We look forward to working with the DoD in the future to help heal our warfighters. Please continue to share our story and updates with your friends and family.

Sincerely,

The SanMelix Team  

Pink Angel Event

9 months ago

Happy Monday everyone,

In recognition of Breast Cancer Awareness month, we attended the Pink Angels Memorial Foundation fundraising event. These strong group of women raise money to help breast cancer patients in need. It’s our goal to help heal these patients with our radiodermatitis cream.


More updates to come! Don't forget to share our campaign with any friends and family!


Notice of Funds Disbursement

9 months ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, SanMelix Laboratories has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in SanMelix Laboratories be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

October Breast Cancer Awareness Month

9 months ago

 Hello, 

SanMelix is  dedicated to supporting patients battling breast cancer and will be launching the only radiodermatitis cream that uses inherent natural healing properties of Buckwheat Honey (available 2020).  In recognition of breast cancer month, we will be attending the Pink Angels Memorial Foundation event this Thursday, October 3rd. Please help us heal others and continue to share our mission with your network and get them to invest in a company that cares.


 

Up to 150 Investors Today

10 months ago

Today is a very big day for SanMelix. We’ve reached 150 investors! This is an amazing milestone and we wanted to take a second to say thank you for your trust and support.  We've decided to extend the StartEngine campaign for another 60 days to maximize our momentum. A small portion of you, (not all of you), will receive a notice with instructions to reconfirm your investment later today. Please follow the instructions the StartEngine Team sends you so that you can stay apart of this round. 

We have big ambitions for this company. If you haven't joined us yet, now is a great time.

Slam-Dunk Winner

10 months ago

Recently Dr. Jason Green, founder of Green Dermatology and Cosmetic Center in Deerfield Beach, Fla., volunteered to help test our BEECure™ R and had patients with SRT (Superficial Radiotherapy) willing to try it. He says he’s had nothing but success, and it’s going to be a slam-dunk winner.  “It relieves tenderness, itchiness and inflammation as well as redness,” says Green. “It basically soothes the skin. It definitely works and it definitely helps. Please share this exciting news with your network and get them to invest in a company that Heals Others!

Sincerely,

The SanMelix Team

Notice of Material Change in Offering

10 months ago

[The following is an automated notice from the StartEngine team].

Hello! Recently, a change was made to the SanMelix Laboratories offering. Here's an excerpt describing the specifics of the change:


Extended length of campaign.


When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.

Notice of Funds Disbursement

10 months ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, SanMelix Laboratories has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in SanMelix Laboratories be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

WOW! We just surpassed 100 Investors. What an Achievement!

11 months ago

What a great month we are having. Surpassed the 100 investor mark and the US Patent and Trademark Office awarded us a patent for our BEECure MGO Advanced Wound Care Dressing.  Great month, great investments. 

Investors who have already contributed please ask your friends and family to invest now! Potential investor, why are you waiting? This is your opportunity to join us and help to heal others.

Sincerely,

The SanMelix Team

Exciting News

11 months ago

Happy Monday, 

Hope you’ve had an amazing summer! We sure did, as we could not be more excited to inform you, our BEECure™ MGO Advanced Wound Care Dressing Patent Was Issued. The patent approval demonstrates the company’s commitment to using robust intellectual property rights to develop visionary consumer, business and medical solutions. This notable achievement allows us to move forward with important initiatives and to speak more openly about our dressings and formulations.  We welcome you to Help Us Heal Others. Please continue to share our story to your network.

Sincerely,

The SanMelix Team

Exciting Milestone Achieved

11 months ago

Dear Shareholders,

Thank you so much for being a part of our crowdfunding campaign! Thanks to you and many others, we reached our equity crowdfunding goal of $107k in under two months. We are in active fundraising mode and continue to build momentum, therefore we made the decision to extend our campaign. We encourage you to share this milestone with others as we believe we have an opportunity to have an important impact on the world. Thank you for your continuous support, and we look forward to the joint path ahead.

Sincerely,

Diana Sabacinski

CEO SanMelix Laboratories, Inc.

Notice of Material Change in Offering

11 months ago

[The following is an automated notice from the StartEngine team].

Hello! Recently, a change was made to the SanMelix Laboratories offering. Here's an excerpt describing the specifics of the change:


Sanmelix has has increased their maximum funding goal.


When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.

Notice of Funds Disbursement

11 months ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, SanMelix Laboratories has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in SanMelix Laboratories be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

An In-Depth Article by Health Journal on our Business

12 months ago

We're proud to announce that since launching  our equity crowd-funding campaign in June to help propel BEECure forward, it quickly caught the attention of the publisher at Health Journal.  This award winning publishing company has designed successful marketing and public relations solutions for hundreds of clients. They recently published an editorial featuring SanMelix and our equity crowdfunding campaign. It's a detailed look at our business and what we're looking to achieve. Check out the article at here

 


 

Notice of Funds Disbursement

12 months ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, SanMelix Laboratories has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in SanMelix Laboratories be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

Show More Updates End of Updates

Comments ({{profileCtrl.startup.comments_count}} total)

{{profileCtrl.newComment.body.length}}/2500
Please sign in to post a comment.
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}